Infliximab reverses growth hormone resistance associated with inflammatory bowel disease.
Vespasiani Gentilucci U, Caviglia R, Picardi A, Carotti S, Ribolsi M, Galati G, Petitti T, Afeltra A, Cicala M.
Vespasiani Gentilucci U, et al. Among authors: cicala m.
Aliment Pharmacol Ther. 2005 May 1;21(9):1063-71. doi: 10.1111/j.1365-2036.2005.02449.x.
Aliment Pharmacol Ther. 2005.
PMID: 15854167
Free article.
Clinical Trial.